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LETTERS
Acanthamoeba spp. 
in Urine of  
Critically Ill Patients
To the Editor: Free-living ame-
bae  are  ubiquitous  protists  able  to 
endure  extreme  temperature  and  pH 
in  diverse  environments  (1).  In  past 
decades, interest in them increased as 
causes of infections, such as keratitis 
(2)  and  granulomatous  encephalitis 
(3).  Acanthamoeba  spp.  can  harbor 
pathogenic  microorganisms  as  endo-
symbionts, such as bacteria (e.g., Le-
gionella  spp.,  Pseudomonas  aerugi-
nosa, and Vibrio cholera), fungi, and 
mycobacteria (4).
The  occasional  observation  of 
amebae in urine specimens in a clinical 
microbiology  laboratory  (by  L.C.S.) 
motivated our study. To estimate the 
prevalence of Acanthamoeba spp. in 
urine,  on  March  3  and  4,  2008,  we 
collected urine samples from indwell-
ing urinary catheters of all critically 
ill patients in the intensive care units 
of a tertiary care 2,000-bed university 
hospital (Hospital das Clínicas, Uni-
versity of São Paulo). Medical records 
were  evaluated  for  patient  age,  sex, 
underlying diseases, length of hospi-
tal stay, use of central venous catheter, 
mechanical  ventilation,  antimicro-
bial drug use, and duration of urinary   
catheterization.
Chemical  urinalysis  was  per-
formed by using a urine dipstick (Uri-
quest;  Labtest  Diagnostica,  Lagoa 
Santa, Minas Gerais, Brazil), and urine 
leukocyte and erythrocyte counts were 
performed.  Samples  were  examined 
microscopically and cultured for ame-
bae.  Amebae  were  characterized  on 
the basis of morphologic criteria (cyst 
morphology  and  trophozoite  shape 
and motility) (5). For ameba culture, 
10  mL  of  urine  was  centrifuged  at 
2,500 rpm for 5 min. The supernatant 
was  discarded,  and  the  sediment  (1 
mL) was added to 5 mL of brain heart 
infusion  (Oxoid,  Cambridge,  UK). 
Cultures were incubated at 25oC for 
48 hr and microscopically examined. 
For this study, finding trophozoites on 
direct examination or growing Acan-
thamoeba on culture were considered 
a positive result for the patient.
Pipet tips (10), vacuum contain-
ers  (10),  plastic  15-mL  tubes  (10), 
syringes  (10),  glass  slides  (20),  and 
tubes  containing  medium  (10)  were 
submitted for direct examination and 
culture for ameba to ensure that they 
were not contaminated. Urine samples 
were cultured for bacteria and fungi. 
Urine samples were submitted for bac-
terial and fungal direct examinations, 
and  cultures  were  performed  (6).  If 
found,  organisms  were  identified  by 
morphologic, biochemical, and Gram 
stain characteristics.
Data from patients with and with-
out  Acanthamoeba  spp.  were  com-
pared. For dichotomous variables, we 
used  χ2  to  calculate  odds  ratios  and 
95%  confidence  intervals.  For  con-
tinuous variables, the Mann-Whitney 
test was used. Results were significant 
at p<0.05.
A total of 63 urine samples were 
evaluated; 17 (26%) were positive for 
Acanthamoeba spp. (Table). All sam-
ples of the control materials and me-
dium tested showed negative results.
The  high  prevalence  of  Acan-
thamoeba spp. in the urine of critically 
ill patients is difficult to explain. Al-
though Acanthamoeba spp. can cause 
severe  infections,  amebae  also  carry 
pathogenic microorganisms (4). Bac-
teria may serve as food for amebae, 
but other interactions exist; for exam-
ple, bacteria take advantage of the pro-
tection offered by amebae, especially 
in the cystic form (4). P. aeruginosa, 
Escherichia coli, and Proteus mirabi-
lis can infect free-living amebae (7). 
The presence of Acanthamoeba spp. 
in  critically  ill  patients  may  be  ad-
vantageous to potentially pathogenic 
bacteria in the urine, protecting them 
against antimicrobial drugs, disinfec-
tants, and host immunity. In this sense 
Acanthamoeba  spp.  may  be  a  reser-
voir  for  pathogenic  bacterial  agents 
in severely ill patients or, as Khan de-
scribed, a “Trojan horse for bacteria” 
(1). However, we found no association 
between the presence of Acanthamoe-
ba spp. of bacteria and fungi in the 
urine.
Biofilms are attractive niches for 
Acanthamoeba spp. that may provide 
nutritional  requirements  and  protec-
tion against disinfectants and antimi-
crobial drugs (1). After 7 days in a pa-
tient, most urinary catheters contain a 
biofilm (8). However, we found no as-
sociation between duration of catheter-
ization and presence of Acanthamoeba 
spp. Also, P. aeruginosa isolates from 
clinical  infections  have  shown  more 
virulence toward Acanthamoeba spp. 
than environmental samples (9).
Another  possible  explanation  is 
the direct pathogenic activity of Acan-
thamoeba spp. In a study to determine 
whether  ameba-associated  microor-
ganisms  are  a  cause  of  nosocomial 
pneumonia, in 5 of 210 cases, Acan-
thamoeba sp. was considered the only 
cause of infection (10). In our study, 
patients  positive  for  Acanthamoeba 
spp. had a higher mean and median 
of urine leukocytes and erythrocytes, 
suggesting aggression by the amebae. 
On the other hand, even these higher 
counts  among  positive  patients  are 
considered  relatively  low.  Cardio-
vascular  disease,  cancer,  and  diabe-
tes  were  associated  with  carriage  of 
Acanthamoeba spp., which may occur 
in more severely ill patients. As a fi-
nal possibility, Acanthamoeba spp. in 
the urine could have no role at all and 
may even reflect contamination during 
catheterization.
This study has limitations. It was 
a  small,  preliminary  investigation 
designed  only  to  evaluate  the  pres-
ence of Acanthamoeba spp. in urine. 
However, our findings should lead to 
further studies to increase knowledge 
about the role of free-living amebae in 
nosocomial infections.
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Table.	Univariate	analysis	of	variables	potentially	associated	with	Acanthamoeba	spp.	in	urine	samples	from	critically	ill	patients,	
Hospital	das	Clínicas,	University	of	São	Paulo,	Brazil,	March	2008*	
Variable
Sample	positive	for	
Acanthamoeba	spp.†	
Sample	negative	for	
Acanthamoeba	spp.‡	 OR 95%	CI	 p	value	
No.	(%)	patients	
	 Male	sex 10	(59) 28	(61) 0.92 0.30–2.95 0.88
	 Antimicrobial	drug	use 13	(77) 35	(76) 1.02 0.28–3.78 0.97
	 Use	of	mechanical	ventilation 10	(59) 23	(70) 1.43 0.46–4.40 0.53
	 Presence	of	central	venous	catheter 12	(75)§ 33	(72) 1.18 0.32–4.34 0.80
	 Urine	culture	positive	for	bacteria/fungi
	 	 Any	count	 9	(53) 21	(46) 1.34 0.44–4.09 0.61
		> 1 0
5	CFU/mL 8	(47) 13	(28) 2.26 0.72–7.12 0.16
	 Underlying	diseases
	 	 Cardiovascular 15	(88) 26	(57) 5.77 1.06–41.34 0.02
	 	 Infectious	diseases 10	(59) 21	(46) 1.70 0.48–6.09 0.35
	 	 Cancer 9	(53) 9	(20) 4.63 1.20–18.40 0.01
	 	 Diabetes	mellitus 5	(29) 3	(7) 5.97 1.02–38.03 0.02
	 	 Renal	Insufficiency 2	(12) 6	(13) 0.89 0.11–5.81 0.89
	 	 Acute	abdomen 2	(12) 4	(9) 1.40 0.16–10.44 0.71
    Trauma 1	(6) 11	(24) 0.20 0.01–1.74 0.11
	 	 Respiratory 1	(6) 5	(11) 0.51 0.02–5.24 0.55
	 	 Neurologic 1	(6) 4	(9) 0.66 0.03–7.19 0.71
	 	 Others 8	(47) 19	(35) 1.26 0.36–4.45 0.68
Age,	y
	 Mean	(SD) 62.4	(13.9) 54.7	(16.2) 0.05
	 Median	(range)	 64.6	(20.5–77.5) 53.4	(17.7–80.8)
Length	of	hospital	stay,	d
	 Mean	(SD) 16.3	(12.8) 13.5	(11.3) 0.45
	 Median	(range)	 11	(2–43) 9	(1–48)
Length	of	ICU	stay,	d
	 Mean	(SD) 6.9	(9.0) 9.4	(10.4) 0.18
	 Median	(range)	 3.0	(1–31) 5.5	(0–47)
Duration	of	urinary	catheterization,	d
	 Mean	(SD) 8.3	(9.8) 10.4	(9.4) 0.17
	 Median	(range)	 4.0	(1–33) 8.5	(1–33)
Leukocyte	count	in	urine	per	high-power	field
	 Mean	(SD) 10.9	(17.4) 3.59	(10.53) 0.009
	 Median	(range)	 3.5	(0–60) 1.0	(0–70)
Erythrocyte	count	in	urine	per	high-power	field
	 Mean	(SD) 35.8	(42.6) 17.7	(27.9) 0.03
	 Median	(range)	 18.5	(0–150) 4.0	(0–120)
Urine	pH
	 Mean	(SD) 5.4	(0.8) 5.8	(1.1) 0.18
	 Median	(range)	 5	(5–8) 5	(5–8.5)
*OR,	odds	ratio;	CI,	confidence	interval.	
†n	=	17	except	as	indicated.	
‡n	=	46.	
§n	=	16.	LETTERS
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Ranavirus  
Outbreak in North 
American Bullfrogs   
(Rana catesbeiana), 
Japan, 2008 
To the Editor: Ranaviruses (fam-
ily Iridoviridae) are emerging patho-
gens  of  farmed  and  wild  amphib-
ians  and  cause  high  mortality  rates 
in  these  animals  (1).  These  viruses 
are  associated  with  massive  popula-
tion decreases of some species (2,3); 
outbreaks  have  been  reported  in  the 
United States, Asia, Micronesia, and 
Europe. At the general meeting held 
by the International Epizootic Office 
in May 2008, iridoviruses of amphibi-
ans were added to the list of pathogens 
of wildlife that should be monitored 
(www.oie.int/aac/eng/Publicat/Card-
senglish/Ranavirus%20card_final.pdf, 
www.oie.int/eng/normes/fcode/en_ 
chapitre_2.4.2.htm, and www.jcu.edu.
au/school/phtm/PHTM/frogs/other 
diseases-viruses.htm).  We  report  an 
outbreak of ranavirus disease in am-
phibians in Japan.
A  mass  die-off  of  wild  North 
American  bullfrog  (Rana  cates-
beiana)  larvae  was  discovered  in  a 
1,000-m2 pond in western Japan. The 
die-off  lasted  from  September  10 
through  October  20,  2008,  with  an 
epidemic peak on September 20, dur-
ing which several thousand carcasses 
were collected daily. No dead adults 
of R. catesbeiana or other amphibian 
species  were  found.  Fish  (families 
Cyprinidae and Gobiidae) in the pond 
were unaffected.
Clinical signs in frogs were de-
pression;  lethargy;  palpebral  hyper-
emia;  abdominal  edema,  petechiae, 
and erythema on the ventral surface; 
skin  ulcers;  limb  and  tail  necrosis; 
and  emaciation.  Pathologic  changes 
were similar in all larvae. At necrop-
sy, subcutaneous edema, body cavity 
effusions, and swollen and friable liv-
ers were observed. Histologic exami-
nation showed extensive glomerular 
necrosis  with  renal  tubular  hyaline 
droplet degeneration (online Appen-
dix Figure, available from www.cdc.
gov/EID/content/15/7/1146-appF.
htm) and various degrees of hepatic 
cell degeneration and necrosis. Myxo-
sporidia  were  not  observed  within 
any  renal  tubules.  Electron  micros-
copy showed cytoplasmic ranavirus-
like  particles  within  glomerular  en-
dothelial cells. These particles were 
icosahedral with a diameter of ≈120 
nm. Bacterial colonies were observed 
on the skin and within multiple or-
gans in some larvae examined. These 
colonies  were  interpreted  to  be  op-
portunistic organisms and microbial 
cultures were not performed.
PCR  with  primers  M153  and 
M154  (4)  amplified  a  ranavirus-
specific gene encoding major capsid 
protein (MCP) from 18 bullfrog speci-
mens. DNA sequences (584 nt, which 
did  not  include  primer-annealing  re-
gions) obtained from 5 PCR products 
randomly selected by direct-sequenc-
ing  were  identical.  These  sequences 
showed highest similarities with those 
of  R.  catesbeiana  virus  TW07–440 
(GenBank  accession  no.  FJ207464); 
only 1 nt difference was observed and 
this  difference  resulted  in  an  amino 
acid substitution. Amplifications with 
several  sets  of  primers  (M68/M69, 
M70/M71, M72/M73, M84/M85, and 
M151/M152) (4) and sequencing were 
conducted. 
We  determined  MCP  DNA  se-
quences of 1,472 nt that included the 
complete coding region (nt positions 
17–1408, 1,392 nt) and proximal flank-
ing regions. Sequences were deposited 
in the DNA Data Bank of Japan/Gen-
Bank/European  Molecular  Biology 
Laboratory DNA databases under the 
accession no. AB474588. Phylogenetic 
analysis showed that virus detected in 
this study, designated RCV-JP, showed 
greater similarity to TW07–440 virus 
than  to  other  ranaviruses,  including 
tadpole edema virus (5), frog virus 3 
(6),  and  R.  catesbeiana  virus  Z  (7). 
Liver  tissues  of  fish  (Gnathopogon 
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